DoD Melanoma, Survivorship Research Award

The Department of Defense (DOD) announces the FY25 Melanoma Survivorship Research Award under the Defense Health Program to support innovative research aimed at improving the health and well-being of melanoma survivors and their caregivers. This program seeks to foster collaborative efforts that incorporate melanoma consumer insights into the research process. Applicants must submit a pre-application by September 10, 2025, followed by a full application due by October 1, 2025, targeting a maximum funding of $725,000 per award over a 3-year performance period. The program emphasizes research on various aspects of melanoma survivorship, including psychological impacts, symptom management, and healthcare delivery challenges. Strategies should address long-term effects of treatment and methods to improve quality of life while avoiding studies limited to animal models or survival rates without quality of life considerations. Key eligibility criteria include having a Principal Investigator from eligible organizations and mandatory collaboration with melanoma consumer partners. The application process involves detailed submission requirements, including budget formulations and clear evidence of support from collaborators. This funding opportunity reflects a commitment to enhancing melanoma care and aligns with military health considerations, aiming to bridge gaps in current research and treatment protocols.